Galmed Pharmaceuticals Announces Publication in “The Journal of Autoimmunity” for its IND ready, Amilo-5MER, a specific anti-inflammatory compound

August 19, 2021 12:00 pm Published by Leave your thoughts

– Amilo-5MER suppresses chronic inflammations in broad spectrum of animal models of inflammatory diseases.

Categorised in:

This post was written by admin

Leave a Reply

Your email address will not be published.